Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 452

1.

Rare haematogenous sarcoma metastasis to the heart in a child - ERRATUM.

Gross GJ, Postovsky S, Khoury A.

Cardiol Young. 2019 Oct 18:1. doi: 10.1017/S1047951119002373. [Epub ahead of print] No abstract available.

PMID:
31623694
2.

Rare haematogenous sarcoma metastasis to the heart in a child.

Gross GJ, Postovsky S, Khoury A.

Cardiol Young. 2019 Oct;29(10):1305-1306. doi: 10.1017/S1047951119002014. Epub 2019 Sep 2.

PMID:
31475648
3.

Epoxyeicosatrienoic acid analog EET-B attenuates post-myocardial infarction remodeling in spontaneously hypertensive rats.

Neckář J, Hye Khan MA, Gross GJ, Cyprová M, Hrdlička J, Kvasilová A, Falck JR, Campbell WB, Sedláková L, Škutová Š, Olejníčková V, Gregorovičová M, Sedmera D, Kolář F, Imig JD.

Clin Sci (Lond). 2019 Apr 29;133(8):939-951. doi: 10.1042/CS20180728. Print 2019 Apr 30.

PMID:
30979784
4.

Ticagrelor for Refractory Migraine/Patent Foramen Ovale (TRACTOR): An open-label pilot study.

Reisman AM, Robbins BT, Chou DE, Yugrakh MS, Gross GJ, Privitera L, Nazif T, Sommer RJ.

Neurology. 2018 Nov 27;91(22):1010-1017. doi: 10.1212/WNL.0000000000006573.

PMID:
30478067
5.

Infarct size-limiting effect of epoxyeicosatrienoic acid analog EET-B is mediated by hypoxia-inducible factor-1α via downregulation of prolyl hydroxylase 3.

Neckář J, Hsu A, Hye Khan MA, Gross GJ, Nithipatikom K, Cyprová M, Benák D, Hlaváčková M, Sotáková-Kašparová D, Falck JR, Sedmera D, Kolář F, Imig JD.

Am J Physiol Heart Circ Physiol. 2018 Nov 1;315(5):H1148-H1158. doi: 10.1152/ajpheart.00726.2017. Epub 2018 Aug 3.

6.

A novel fibroblast growth factor-1 ligand with reduced heparin binding protects the heart against ischemia-reperfusion injury in the presence of heparin co-administration.

Huang C, Liu Y, Beenken A, Jiang L, Gao X, Huang Z, Hsu A, Gross GJ, Wang YG, Mohammadi M, Schultz JEJ.

Cardiovasc Res. 2017 Nov 1;113(13):1585-1602. doi: 10.1093/cvr/cvx165.

7.

Transient receptor potential vanilloid 1 inhibitors block laparotomy- and opioid-induced infarct size reduction in rats.

Heymann HM, Wu Y, Lu Y, Qvit N, Gross GJ, Gross ER.

Br J Pharmacol. 2017 Dec;174(24):4826-4835. doi: 10.1111/bph.14064. Epub 2017 Nov 21.

8.

Cardiac findings in children with juvenile Dermatomyositis at disease presentation.

Cantez S, Gross GJ, MacLusky I, Feldman BM.

Pediatr Rheumatol Online J. 2017 Jul 11;15(1):54. doi: 10.1186/s12969-017-0182-0.

9.

External Trigeminal Nerve Stimulation for the Acute Treatment of Migraine: Open-Label Trial on Safety and Efficacy.

Chou DE, Gross GJ, Casadei CH, Yugrakh MS.

Neuromodulation. 2017 Oct;20(7):678-683. doi: 10.1111/ner.12623. Epub 2017 Jun 5.

PMID:
28580703
10.

Transient Receptor Potential Vanilloid 1 Regulates Mitochondrial Membrane Potential and Myocardial Reperfusion Injury.

Hurt CM, Lu Y, Stary CM, Piplani H, Small BA, Urban TJ, Qvit N, Gross GJ, Mochly-Rosen D, Gross ER.

J Am Heart Assoc. 2016 Sep 26;5(9). pii: e003774.

11.

Intestinal Microbial Metabolites Are Linked to Severity of Myocardial Infarction in Rats.

Lam V, Su J, Hsu A, Gross GJ, Salzman NH, Baker JE.

PLoS One. 2016 Aug 9;11(8):e0160840. doi: 10.1371/journal.pone.0160840. eCollection 2016.

12.

Morphine Reduces Myocardial Infarct Size via Heat Shock Protein 90 in Rodents.

Small BA, Lu Y, Hsu AK, Gross GJ, Gross ER.

Biomed Res Int. 2015;2015:129612. doi: 10.1155/2015/129612. Epub 2015 Aug 27.

13.

Thrombopoietin receptor agonists protect human cardiac myocytes from injury by activation of cell survival pathways.

Baker JE, Su J, Koprowski S, Dhanasekaran A, Aufderheide TP, Gross GJ.

J Pharmacol Exp Ther. 2015 Mar;352(3):429-37. doi: 10.1124/jpet.114.221747. Epub 2014 Dec 15.

PMID:
25512369
14.

Lone atrial fibrillation in the pediatric population.

Mills LC, Gow RM, Myers K, Kantoch MJ, Gross GJ, Fournier A, Sanatani S.

Can J Cardiol. 2013 Oct;29(10):1227-33. doi: 10.1016/j.cjca.2013.06.014.

PMID:
24074972
15.

Nociceptive-induced myocardial remote conditioning is mediated by neuronal gamma protein kinase C.

Gross ER, Hsu AK, Urban TJ, Mochly-Rosen D, Gross GJ.

Basic Res Cardiol. 2013 Sep;108(5):381. doi: 10.1007/s00395-013-0381-x. Epub 2013 Aug 28.

16.

Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes.

Nunes SS, Miklas JW, Liu J, Aschar-Sobbi R, Xiao Y, Zhang B, Jiang J, Massé S, Gagliardi M, Hsieh A, Thavandiran N, Laflamme MA, Nanthakumar K, Gross GJ, Backx PH, Keller G, Radisic M.

Nat Methods. 2013 Aug;10(8):781-7. doi: 10.1038/nmeth.2524. Epub 2013 Jun 23.

17.

Mutation location effect on severity of phenotype during exercise testing in type 1 long-QT syndrome: impact of transmembrane and C-loop location.

Laksman ZW, Hamilton RM, Chockalingam P, Ballantyne E, Stephenson EA, Gross GJ, Gula LJ, Klein GJ, Wilde AA, Krahn AD.

J Cardiovasc Electrophysiol. 2013 Sep;24(9):1015-20. doi: 10.1111/jce.12172. Epub 2013 May 20.

PMID:
23691991
18.
19.

Acute and chronic cardioprotection by the enkephalin analogue, Eribis peptide 94, is mediated via activation of nitric oxide synthase and adenosine triphosphate-regulated potassium channels.

Gross GJ, Hsu A, Nithipatikom K, Pfeiffer AW, Bobrova I, Bissessar E.

Pharmacology. 2012;90(1-2):110-6. doi: 10.1159/000340058. Epub 2012 Jul 18.

20.

Factors mediating remote preconditioning of trauma in the rat heart: central role of the cytochrome p450 epoxygenase pathway in mediating infarct size reduction.

Gross GJ, Hsu A, Gross ER, Falck JR, Nithipatikom K.

J Cardiovasc Pharmacol Ther. 2013 Jan;18(1):38-45. doi: 10.1177/1074248412437586. Epub 2012 Mar 9.

21.

Intestinal microbiota determine severity of myocardial infarction in rats.

Lam V, Su J, Koprowski S, Hsu A, Tweddell JS, Rafiee P, Gross GJ, Salzman NH, Baker JE.

FASEB J. 2012 Apr;26(4):1727-35. doi: 10.1096/fj.11-197921. Epub 2012 Jan 12.

22.

Eribis peptide 94 reduces infarct size in rat hearts via activation of centrally located μ opioid receptors.

Gross GJ, Hsu A, Nithipatikom K, Bobrova I, Bissessar E.

J Cardiovasc Pharmacol. 2012 Feb;59(2):194-7. doi: 10.1097/FJC.0b013e318241e8c7.

23.

Dose-dependent cardioprotection of enkephalin analogue Eribis peptide 94 and cardiac expression of opioid receptors in a porcine model of ischaemia and reperfusion.

Karlsson LO, Bergh N, Li L, Bissessar E, Bobrova I, Gross GJ, Akyürek LM, Grip L.

Eur J Pharmacol. 2012 Jan 15;674(2-3):378-83. doi: 10.1016/j.ejphar.2011.11.012. Epub 2011 Nov 16.

PMID:
22119384
24.

Protection from myocardial ischemia/reperfusion injury by a positive allosteric modulator of the A₃ adenosine receptor.

Du L, Gao ZG, Nithipatikom K, Ijzerman AP, Veldhoven JP, Jacobson KA, Gross GJ, Auchampach JA.

J Pharmacol Exp Ther. 2012 Jan;340(1):210-7. doi: 10.1124/jpet.111.187559. Epub 2011 Oct 19.

25.

The effect of NavX on fluoroscopy times in pediatric catheter ablation.

Kwong W, Neilson AL, Chiu CC, Gross GJ, Hamilton RM, Soucie L, Stephenson EA, Kirsh JA.

J Interv Card Electrophysiol. 2012 Jan;33(1):123-6. doi: 10.1007/s10840-011-9604-y. Epub 2011 Oct 18.

PMID:
22006437
26.

Abdominal surgical incision induces remote preconditioning of trauma (RPCT) via activation of bradykinin receptors (BK2R) and the cytochrome P450 epoxygenase pathway in canine hearts.

Gross GJ, Baker JE, Moore J, Falck JR, Nithipatikom K.

Cardiovasc Drugs Ther. 2011 Dec;25(6):517-22. doi: 10.1007/s10557-011-6321-9.

27.

Characterization of a critical role for CFTR chloride channels in cardioprotection against ischemia/reperfusion injury.

Xiang SY, Ye LL, Duan LL, Liu LH, Ge ZD, Auchampach JA, Gross GJ, Duan DD.

Acta Pharmacol Sin. 2011 Jun;32(6):824-33. doi: 10.1038/aps.2011.61.

28.

The neonatal but not the mature heart adapts to acute tachycardia by beneficial modification of the force-frequency relationship.

Schmidt MR, White PA, Khambadkone S, Gross GJ, Bøtker HE, Vogel M, Hjortdal VE, Sørensen KE, Redington AN.

Pediatr Cardiol. 2011 Jun;32(5):562-7. doi: 10.1007/s00246-011-9899-6. Epub 2011 Mar 11.

PMID:
21394656
29.

Arrhythmia and sudden death associated with elevated cardiac chloride channel activity.

Ye L, Zhu W, Backx PH, Cortez MA, Wu J, Chow YH, McKerlie C, Wang A, Tsui LC, Gross GJ, Hu J.

J Cell Mol Med. 2011 Nov;15(11):2307-16. doi: 10.1111/j.1582-4934.2010.01243.x.

30.

Are we putting too much stock in mice?

Auchampach JA, Maas JE, Wan TC, Figler RA, Gross GJ.

J Mol Cell Cardiol. 2011 Mar;50(3):584-5. doi: 10.1016/j.yjmcc.2010.11.016. Epub 2010 Dec 1. No abstract available.

PMID:
21129379
31.

Effect on ex vivo platelet aggregation and in vivo cyclic flow with Na+/H+ exchange inhibition: Gumina, NHE-1 inhibition and platelet aggregation.

Gumina RJ, Newman PJ, Gross GJ.

J Thromb Thrombolysis. 2011 May;31(4):431-5. doi: 10.1007/s11239-010-0530-0.

32.

A combined gene and cell therapy approach for restoration of conduction.

Hofshi A, Itzhaki I, Gepstein A, Arbel G, Gross GJ, Gepstein L.

Heart Rhythm. 2011 Jan;8(1):121-30. doi: 10.1016/j.hrthm.2010.10.011. Epub 2010 Oct 14.

PMID:
20951232
33.

Sustained ligand-activated preconditioning via δ-opioid receptors.

Peart JN, Hoe LE, Gross GJ, Headrick JP.

J Pharmacol Exp Ther. 2011 Jan;336(1):274-81. doi: 10.1124/jpet.110.172593. Epub 2010 Oct 14.

34.

Central nervous system abnormalities in two cases with neonatal Marfan syndrome with novel mutations in the fibrillin-1 gene.

Barnett CP, Wilson GJ, Chiasson DA, Gross GJ, Hinek A, Hawkins C, Chitayat D.

Am J Med Genet A. 2010 Sep;152A(9):2409-12. doi: 10.1002/ajmg.a.33406. No abstract available.

PMID:
20803651
35.

Evidence that the acute phase of ischemic preconditioning does not require signaling by the A 2B adenosine receptor.

Maas JE, Wan TC, Figler RA, Gross GJ, Auchampach JA.

J Mol Cell Cardiol. 2010 Nov;49(5):886-93. doi: 10.1016/j.yjmcc.2010.08.015. Epub 2010 Aug 24.

36.

Diagnosis-specific characteristics of ventricular tachycardia in children with structurally normal hearts.

Wang S, Zhu W, Hamilton RM, Kirsh JA, Stephenson EA, Gross GJ.

Heart Rhythm. 2010 Dec;7(12):1725-31. doi: 10.1016/j.hrthm.2010.07.037. Epub 2010 Aug 4.

PMID:
20691281
37.

Evidence for a role of opioids in epoxyeicosatrienoic acid-induced cardioprotection in rat hearts.

Gross GJ, Baker JE, Hsu A, Wu HE, Falck JR, Nithipatikom K.

Am J Physiol Heart Circ Physiol. 2010 Jun;298(6):H2201-7. doi: 10.1152/ajpheart.00815.2009. Epub 2010 Apr 16.

38.

Review article: epoxyeicosatrienoic acids: novel mediators of cardioprotection.

Nithipatikom K, Gross GJ.

J Cardiovasc Pharmacol Ther. 2010 Jun;15(2):112-9. doi: 10.1177/1074248409358408. Epub 2010 Mar 3. Review.

PMID:
20200327
39.

Early repolarization and ventricular fibrillation: vagally familiar?

Gross GJ.

Heart Rhythm. 2010 May;7(5):653-4. doi: 10.1016/j.hrthm.2010.02.008. Epub 2010 Feb 11. No abstract available.

PMID:
20153448
40.

Isoflurane postconditioning protects against reperfusion injury by preventing mitochondrial permeability transition by an endothelial nitric oxide synthase-dependent mechanism.

Ge ZD, Pravdic D, Bienengraeber M, Pratt PF Jr, Auchampach JA, Gross GJ, Kersten JR, Warltier DC.

Anesthesiology. 2010 Jan;112(1):73-85. doi: 10.1097/ALN.0b013e3181c4a607.

41.

Acute methadone treatment reduces myocardial infarct size via the delta-opioid receptor in rats during reperfusion.

Gross ER, Hsu AK, Gross GJ.

Anesth Analg. 2009 Nov;109(5):1395-402. doi: 10.1213/ANE.0b013e3181b92201.

42.

The effect of weight training on bone mineral density and bone turnover in postmenopausal breast cancer survivors with bone loss: a 24-month randomized controlled trial.

Waltman NL, Twiss JJ, Ott CD, Gross GJ, Lindsey AM, Moore TE, Berg K, Kupzyk K.

Osteoporos Int. 2010 Aug;21(8):1361-9. doi: 10.1007/s00198-009-1083-y. Epub 2009 Oct 3.

PMID:
19802506
43.

Utility of exercise testing in children and teenagers with arrhythmogenic right ventricular cardiomyopathy.

Sequeira IB, Kirsh JA, Hamilton RM, Russell JL, Gross GJ.

Am J Cardiol. 2009 Aug 1;104(3):411-3. doi: 10.1016/j.amjcard.2009.03.056. Epub 2009 Jun 6.

PMID:
19616676
44.

Diagnostic usefulness of graded exercise testing in pediatric supraventricular tachycardia.

Draper DE, Giddins NG, McCort J, Gross GJ.

Can J Cardiol. 2009 Jul;25(7):407-10.

45.

Evidence for role of epoxyeicosatrienoic acids in mediating ischemic preconditioning and postconditioning in dog.

Gross GJ, Gauthier KM, Moore J, Campbell WB, Falck JR, Nithipatikom K.

Am J Physiol Heart Circ Physiol. 2009 Jul;297(1):H47-52. doi: 10.1152/ajpheart.01084.2008. Epub 2009 May 15.

46.

An exercise intervention for breast cancer survivors with bone loss.

Twiss JJ, Waltman NL, Berg K, Ott CD, Gross GJ, Lindsey AM.

J Nurs Scholarsh. 2009 Mar;41(1):20-7. doi: 10.1111/j.1547-5069.2009.01247.x.

PMID:
19335674
47.

Soluble epoxide hydrolase: a new target for cardioprotection.

Gross GJ, Nithipatikom K.

Curr Opin Investig Drugs. 2009 Mar;10(3):253-8. Review.

48.

Vitamin D insufficiency and musculoskeletal symptoms in breast cancer survivors on aromatase inhibitor therapy.

Waltman NL, Ott CD, Twiss JJ, Gross GJ, Lindsey AM.

Cancer Nurs. 2009 Mar-Apr;32(2):143-50. doi: 10.1097/01.NCC.0000339262.44560.92.

49.

Ischemic Preconditioning And Myocardial Infarction: An Update and Perspective.

Gross ER, Gross GJ.

Drug Discov Today Dis Mech. 2007;4(3):165-174.

50.

A prospective pediatric clinical trial of digital music players: do they interfere with pacemakers?

Chiu CC, Huh J, De Souza L, Alfaro-Ramirez A, Clegg R, Fenwick L, Hamilton RM, Kirsh JA, Gross GJ, Gao D, Stephenson EA.

J Cardiovasc Electrophysiol. 2009 Jan;20(1):44-9. doi: 10.1111/j.1540-8167.2008.01270.x. Epub 2008 Aug 6.

PMID:
18691233

Supplemental Content

Loading ...
Support Center